Merck

“Even under current expedited review pathways, it could take years — potentially as many as 10 — to meet the safety and efficacy requirements to obtain FDA approval and then begin manufacturing and commercialization”

Merck · said date not stated · reported 2026-08-20

Estimating the multi-year process required to approve and manufacture single-disease vaccine shots.